GlaxoSmithKline expands Canada plant, adds production of topical pain reliever

GlaxoSmithKline, which has bet big on its consumer health operations, has made a small investment in a manufacturing site in Canada in part so that it can add production of an over-the-counter pain reliever. The expansion comes even as the drugmaker is preparing to make companywide cuts.